The Effects of Sacubitril/Valsartan Compared to Olmesartan on the Blood Pressure and Glucolipid Metabolism in DM Patients with Primary Hypertension.

Shuang ZhangZheng YinZhi-Fan LiWen-Jia ZhangYong-Gang SuiYan-Lu XuHai-Tao ZhangXiao-Ning LiuHong QiuJing-Lin ZhaoJian-Jun LiKe-Fei DouJie QianNa-Qiong Wu

Published in: Cardiovascular drugs and therapy (2023)

Sacubitril/valsartan not only provided superior BP reduction compared to olmesartan, it did so without adverse effects on glycemic control and lipid parameters in DM patients with primary hypertension.

Keyphrases

glycemic control
blood pressure
type diabetes
blood glucose
hypertensive patients
ejection fraction
heart rate
weight loss
insulin resistance
adipose tissue
skeletal muscle
drug induced